A difference of opinion
4th December 2015
Patient costs are not expected to increase after a range of OTC medicines are delisted from the PBS next year, the Department of Health believes.
As reported by Pharmacy News, health advocacy groups are starting to express concerns over a potential increase in costs for concession card holders and the chronically ill.
However, the Department of Health says while it will “monitor the impact of the delisting of the OTC medicines and provide this information to the PBAC”, it remains confident that consumers will pay less for these